Deltec Asset Management’s Revance Therapeutics, Inc. RVNC Stock Holding History

Deltec Asset Management’s Portfolio RVNC Stock Details RVNC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-100,000	Closed	-$304K	–	185
2024 Q4	$304K	Buy	+100,000	New	+$436K	0.06%	138

Other funds holding RVNC

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Deltec Asset Management's RVNC Position: Q1 2025 in Review

Deltec Asset Management sold out of Revance Therapeutics, Inc. (RVNC) in Q1 2025, closing a stake of 100,000 shares — an estimated $304K sold.

Deltec Asset Management first reported a position in RVNC in Q4 2024 and held it in 1 quarter. The position peaked at $304K in Q4 2024. 1 fund tracked by Wall St. Rank holds RVNC as of Q1 2025.

Deltec Asset Management reported no remaining Revance Therapeutics, Inc. position as of Q1 2025 after selling out during the quarter.
Deltec Asset Management sold 100,000 Revance Therapeutics, Inc. shares in Q1 2025, an estimated $304K.
Deltec Asset Management first reported a position in Revance Therapeutics, Inc. in Q4 2024 and held it in 1 quarter.
Deltec Asset Management's Revance Therapeutics, Inc. position peaked at $304K in Q4 2024.
1 fund tracked by Wall St. Rank held Revance Therapeutics, Inc. as of Q1 2025.

Based on Deltec Asset Management's 13F filing for Q1 2025, filed 22 Apr 2025.